Abstract:Aim: Recent progress in cancer immunotherapy has shown its promise and prompted researchers to develop novel therapeutic strategies. Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating adaptive anti-tumor immunity, therefore a promising target for cancer treatment. Here, anti-tumor activities of DC-targeting chemokines were explored in murine colorectal tumor models. Methods: The correlation of chemokine messenger RNA (mRNA) expression with DC markers was analyzed using The Cancer Genome Atlas (TCGA) dataset. Murine colorectal tumor cell lines (CT26 and MC38) stably overexpressing mouse C-C motif chemokine ligand 3 (CCL3), CCL19, CCL21, and X-C motif chemokine ligand 1 (XCL1) were established by lentiviral transduction. The effect of chemokines on tumor cell proliferation/survival was evaluated in vitro by cell counting kit-8 (CCK-8) assay and colony formation assay. Syngeneic subcutaneous tumor models were used to study the effects of these chemokines on tumor growth. Ki-67 expression in tumors was examined by immunohistochemistry. Immune cells in the tumor microenvironment (TME) and lymph nodes were analyzed by flow cytometry. Results: Expression of the four chemokines was positively correlated with the two DC markers [integrin alpha X (ITGAX) and CLEC9A] in human colorectal tumor samples. Tumoral overexpression of DC-targeting chemokines had little or no effect on tumor cell proliferation/survival in vitro while significantly suppressing tumor growth in vivo. Fluorescence-activated cell sorting (FACS) analysis showed that CCL19, CCL21, and XCL1 boosted the ratios of DCs and T cells in CD45+ leukocytes while CCL3 increased the percentage of CD45+ leukocytes in total cells in MC38 tumor. XCL1 had an additional positive effect on antigen uptake by DCs in the TME and antigen transfer to tumor-draining lymph nodes. Conclusions: CCL3, CCL19, CCL21, and XCL1 exhibited potent anti-tumor activities in vivo, although they might differentially regulate immune cells in the TME and antigen transfer to lymph nodes.

Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis

NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma

Notch signaling pathway dampens tumor-infiltrating CD8 + T cells activity in patients with colorectal carcinoma.

Notch1 Regulates the Growth of Human Colon Cancers

Mutations in the Notch Signalling Pathway Are Associated with Enhanced Anti‐tumour Immunity in Colorectal Cancer

Notch2 Expression Is Decreased in Colorectal Cancer and Related to Tumor Differentiation Status

Toll-like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer.

Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment

Notch dimerization contributes to maintenance of intestinal homeostasis by a mechanism involving HDAC2

Dendritic Cell-Targeting Chemokines Inhibit Colorectal Cancer Progression

Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway

A study on DH-1/Notch signal transduction pathway in colorectal cancer

Dysregulation of the MiR-324-5p-CUEDC2 Axis Leads to Macrophage Dysfunction and is Associated with Colon Cancer

GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis

Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia

The Blockage of Notch Signalling Promoted the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells with Lower Immunosuppression.

The Transcription Factor RBP-J-mediated Signaling is Essential for Dendritic Cells to Evoke Efficient Anti-Tumor Immune Responses in Mice

Blocking Dectin-1 Prevents Colorectal Tumorigenesis by Suppressing Prostaglandin E2 Production in Myeloid-Derived Suppressor Cells and Enhancing IL-22 Binding Protein Expression

Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer

F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis